Research found just 4% of trials over the past decade allowed the inclusion of pregnant women.

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...

Clinical research sites face an information challenge that hinders efficiency and collaboration. As trial complexity increases, the multiple logins, devices, and spreadsheets site staff use to execute ...

The UK’s National Health Service (NHS) has been awarded £47.8m ($63.8m) from the National Institute for Health and Care Research (NIHR) to pay for equipment that will increase the NHS’s ability to ...

Nearly all current cancer treatments started in a clinical trial. These research studies help us find better ways to prevent, diagnose, and treat cancer. At any given time, Huntsman Cancer Institute ...

No matter how hard this is, I still recommend clinical trials. Not as a last resort, but as an important option when weighing treatment choices. I don’t know what choice I’ll make, but I’m thankful ...

Over the past decade, the University of Alabama at Birmingham has become a national leader in clinical trials — studies examining the use of new treatments in people. Every drug, device and other ...

New drugs and devices are transforming the treatment of diseases that affect millions of Americans, including cancer, diabetes, sleep apnea and obesity. At the same time, gene therapies are giving ...

Pilot studies and feasibility trials form a critical component of the clinical research process by enabling investigators to assess the practicality of study protocols on a smaller scale prior to ...

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...

In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more risk‑proportionate approach and place transparency obligations on a clear ...